Lava Medtech Acquisition Stock Debt To Equity
| LVACDelisted Stock | USD 10.44 0.00 0.00% |
LAVA Medtech Acquisition fundamentals help investors to digest information that contributes to LAVA Medtech's financial success or failures. It also enables traders to predict the movement of LAVA Stock. The fundamental analysis module provides a way to measure LAVA Medtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LAVA Medtech stock.
LAVA |
LAVA Medtech Acquisition Company Debt To Equity Analysis
LAVA Medtech's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current LAVA Medtech Debt To Equity | 4.92 % |
Most of LAVA Medtech's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LAVA Medtech Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, LAVA Medtech Acquisition has a Debt To Equity of 4.923%. This is 85.01% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The debt to equity for all United States stocks is 89.89% higher than that of the company.
LAVA Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LAVA Medtech's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LAVA Medtech could also be used in its relative valuation, which is a method of valuing LAVA Medtech by comparing valuation metrics of similar companies.LAVA Medtech is currently under evaluation in debt to equity category among its peers.
LAVA Fundamentals
| Return On Asset | -0.0081 | |||
| Current Valuation | 144.92 M | |||
| Shares Outstanding | 11.5 M | |||
| Shares Owned By Institutions | 92.16 % | |||
| Number Of Shares Shorted | 6.82 K | |||
| Price To Book | 1.27 X | |||
| EBITDA | (6.22 M) | |||
| Net Income | 4.5 M | |||
| Cash And Equivalents | 1.15 M | |||
| Cash Per Share | 0.08 X | |||
| Total Debt | 92.81 K | |||
| Debt To Equity | 4.92 % | |||
| Current Ratio | 18.29 X | |||
| Book Value Per Share | (0.21) X | |||
| Cash Flow From Operations | (658.82 K) | |||
| Short Ratio | 0.08 X | |||
| Earnings Per Share | 0.31 X | |||
| Market Capitalization | 149.93 M | |||
| Total Asset | 120.67 M | |||
| Retained Earnings | (3.01 M) | |||
| Working Capital | (3.39 M) | |||
| Net Asset | 120.67 M |
About LAVA Medtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LAVA Medtech Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LAVA Medtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LAVA Medtech Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in LAVA Stock
If you are still planning to invest in LAVA Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LAVA Medtech's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |